PRELUDE CAPITAL MANAGEMENT, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1387508
NEW YORK, NY
Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$463,913
+$208,425 QoQ
Shares Held
744
+124.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#827
of 1,322 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Dec 31, 2020CallValue
$0
CallShares
0
PutValue
$966,220
PutShares
2,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $41,687,806 across 71 Biotechnology names. REGN ranks #16 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
58,590 | $7,776,650 | |
| 2 | TECH |
BIO-TECHNE Corp
|
91,696 | $6,478,322 | |
| 3 | PGEN |
Precigen, Inc.
|
882,267 | $5,028,921 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
113,104 | $4,002,750 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
10,997 | $2,059,518 | |
| 6 | QURE |
uniQure N.V.
|
32,229 | $1,484,467 | |
| 7 | MDXG |
Mimedx Group, Inc.
|
215,239 | $828,670 | |
| 8 | CGON |
CG Oncology, Inc.
|
10,811 | $768,121 |
All Filings in REGN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $463,913 | 744 | Shares | Other | 2026-08-14 | |
| 2025-12-31 | $255,488 | 331 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $258,825 | 493 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $225,785 | 356 | Shares | Other | 2025-05-15 | |
| 2024-09-30 | $611,821 | 582 | Shares | Other | 2024-11-14 | |
| 2023-06-30 | $497,229 | 692 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $403,439 | 491 | Shares | Other | 2023-06-01 | |
| 2021-12-31 | $723,090 | 1,145 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $497,457 | 822 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,109,260 | 1,986 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $548,812 | 1,136 | Shares | Other | 2021-02-16 | |
| 2020-12-31 | $966,220 | 2,000 | Put | Other | 2021-02-16 | |
| 2020-09-30 | $492,046 | 879 | Shares | Other | 2020-11-16 | |
| 2020-09-30 | $1,119,560 | 2,000 | Put | Other | 2020-11-16 | |
| 2020-06-30 | $1,247,300 | 2,000 | Put | Other | 2020-08-14 | |
| 2020-06-30 | $791,411 | 1,269 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $67,384 | 138 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||